RTW INVESTMENTS LP 13D/13G Filings for Dicerna Pharmaceuticals, Inc. (DRNA)

RTW INVESTMENTS LP 13D and 13G filings for Dicerna Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
10:01 am
Purchase
2020-12-3113GDicerna Pharmaceuticals, Inc.
DRNA
RTW INVESTMENTS LP7,253,857
9.670%
1,379,628increase
(+23.49%)
Filing